AIVITA Biomedical to Exhibit Skincare Products at Upcoming Conferences for Aesthetic and Skincare Medical Professionals
IRVINE, Calif. – May 9, 2018 – AIVITA Biomedical today announced that it will be exhibiting at two upcoming aesthetics…
AIVITA Biomedical CEO Hans Keirstead to Deliver Plenary Keynote at GTCbio’s 15th Stem Cell Summit
IRVINE, Calif. – April 11, 2018 – AIVITA Biomedical today announced that Chief Executive Officer Hans Keirstead, Ph.D. will be…
AIVITA Biomedical Scientists Invited to Deliver Keynote Address at HAPPI Anti-Aging Conference
IRVINE, Calif. – March 14, 2018 – AIVITA Biomedical, a global biotech specializing in innovative stem cell applications, announced today…
AIVITA Biomedical to Participate at Upcoming February and March Aesthetic & Dermatology Conferences
IRVINE, Calif. – February 27, 2018 – AIVITA Biomedical, a global bio-tech wellness company specializing in novel stem cell applications,…
AIVITA Biomedical Announces First Patient Enrolled in Phase II Clinical Trial for Late-Stage Ovarian Cancer
IRVINE, Calif. – December 20, 2017 – AIVITA Biomedical today announced that the first patient has been enrolled in its…
AIVITA Biomedical Executes Deal with Lacore Labs for Asian Distribution of a New Skincare Line
IRVINE, Calif. – December 07, 2017 – AIVITA Biomedical today announced the execution of a deal with custom formulator and…
AIVITA Biomedical CEO Dr. Hans Keirstead to speak at Exponential Medicine
IRVINE, Calif. – November 6, 2017 – AIVITA Biomedical CEO Dr. Hans Keirstead is scheduled to speak at Exponential Medicine,…
Renowned Dermatologist Dr. Michael H. Gold Joins AIVITA Scientific Advisory Board
IRVINE, Calif. – September 21, 2017 – AIVITA Biomedical, a clinical research company and commercial skincare product developer, announced today…
AIVITA Biomedical Announces New Discovery with Applications to Regenerative Medicine, Skin Aging and Hair Growth
IRVINE, Calif. September 19, 2017 – AIVITA Biomedical today announced the discovery of a new method for capturing and using…
AIVITA Comments on Positive Findings from Asterias’ SCiStar Trial for Spinal Cord Injury
IRVINE, C.A., June 13, 2017 – AIVITA Biomedical offered its congratulations today following the announcement of positive 9-month efficacy…